Competition Law and Antitrust Law

This comprehensive global competition law update examines recent enforcement actions, regulatory developments, and judicial decisions across multiple jurisdictions including the United States...

On June 4, 2026, Crowell Partners Caroline Brown and Anand Sithian hosted the ACSS New York Chapter at the New York office for an in-person panel discussion titled...

The Department of Justice recently announced that Bayer CropScience voluntarily removed potentially anticompetitive provisions from its Premier Performance Program during an ongoing investigation. The program's tying arrangements and exclusivity incentives raised concerns about foreclosing competition in seed markets, highlighting critical antitrust risks that companies with loyalty programs should evaluate before facing enforcement scrutiny.

Rising tariff rates under the Trump Administration are creating significant financial pressures for importers beyond the duties themselves, particularly through increased customs bond requirements and stricter surety underwriting standards.

Beyond well-known antitrust exemptions like state-action immunity and the baseball exemption, Congress has carved out numerous lesser-known immunities for specific industries and activities.

The U.S. Trade Representative has determined that Brazil's policies across six areas—including digital trade restrictions, preferential tariffs, anti-corruption enforcement failures, intellectual property gaps...

Four major fragrance manufacturers face allegations of price-fixing in a consolidated class action, with companies that purchased fragrance ingredients between 2018 and 2023 potentially having claims. Following a partial settlement by IFF for $44 million, affected purchasers must decide whether to remain in the settlement class or opt out to pursue individual claims.

States are continuing their increased antitrust legislative and enforcement efforts for healthcare transactions, with Maine and Washington recently expanding their antitrust filing...

Global M&A activity in Q1 2026 reached $861.1B, marking a 9.7% increase from the previous year and the strongest start since 2021. With megadeals, cross-border expansion, and sector concentration reshaping the landscape, companies face heightened challenges in antitrust risk, due diligence complexity, and post-transaction litigation exposure.